M&A Deal Summary |
|
---|---|
Date | 2017-01-07 |
Target | Generis Farmacêutica S.A. |
Sector | Life Science |
Buyer(s) | Aurobindo Pharma |
Sellers(s) | Magnum Capital Industrial Partners |
Deal Type | Add-on Acquisition |
Deal Value | 135M EUR |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1986 |
Sector | Life Science |
Employees | 19,364 |
Revenue | 287.0B INR (2024) |
Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s manufacturing facilities are approved by several leading regulatory agencies like US FDA, UK MHRA, Japan PMDA, WHO, Health Canada, MCC South Africa, ANVISA Brazil. Aurobindo Pharma was founded in 1986 and is based in Hyderabad, India.
DEAL STATS | # |
---|---|
Overall | 3 of 4 |
Sector (Life Science) | 3 of 4 |
Type (Add-on Acquisition) | 2 of 3 |
Country (Portugal) | 1 of 2 |
Year (2017) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-09-13 |
Hyacinths Pharma Pvt.
India Hyacinths Pharma Pvt. Ltd. is a provider of active pharmaceutical ingredients. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-01-09 |
GENERIS Farmacêutica S.A.
Amadora, Portugal GENERIS® Farmacêutica, S.A. is a drug development, contract manufacturing and licensing-out company specialized in the manufacturing of solid oral dosage forms. |
Buy | €135M |
Category | Private Equity Firm |
---|---|
Founded | 2006 |
PE ASSETS | 1.0B EUR |
Size | Large |
Type | Sector Agnostic |
Magnum Capital is a private equity firm focused on investing in upper middle-market companies located in Spain and Portugal. Magnum prefers control investments in the industrial and service sectors. The Firm's target investment size is €30 to €100 million in businesses valued from €150 to €800 million. Prospective investment situations include family-owned companies with potential for 'increased operating efficiencies', corporate spin-offs, shareholder liquidity needs, and Iberian companies looking to expand beyond the local area. Magnum Capital was formed in 2006 and has offices in Madrid and Lisbon.
DEAL STATS | # |
---|---|
Overall | 7 of 16 |
Sector (Life Science) | 2 of 2 |
Type (Add-on Acquisition) | 1 of 6 |
Country (Portugal) | 3 of 3 |
Year (2017) | 4 of 6 |
Size (of disclosed) | 4 of 6 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-01-07 |
GENERIS Farmacêutica S.A.
Amadora, Portugal GENERIS® Farmacêutica, S.A. is a drug development, contract manufacturing and licensing-out company specialized in the manufacturing of solid oral dosage forms. |
Sell | USD135M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-02-22 |
Globeducate
Madrid, Spain Globeducate is a provider of technical training and certification programs, conferences, industry standards, reports, publications, technical journals, and government relations activities. Globeducate was founded in 1972 and is based in Madrid, Spain. |
Sell | - |